Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Hamadani
Mehdi
M
Awab
Ahmed
A
Chaudhary
Lubna
L
Tfayli
Arafat
A
D000932:Antiemetics / Q000627:therapeutic use*; D017829:Granisetron / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007546:Isoquinolines / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017294:Ondansetron / Q000627:therapeutic use*; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077924:Palonosetron; D011807:Quinolizines / Q000627:therapeutic use*; D011812:Quinuclidines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D017829:Granisetron; D007211:Indoles; D007546:Isoquinolines; D017294:Ondansetron; D009944:Organoplatinum Compounds; D000077924:Palonosetron; D011807:Quinolizines; D011812:Quinuclidines; C060344:dolasetron